From Data to Knowledge: A Mini-Review on Molecular Network Modeling and Analysis for Therapeutic Target Discovery

Mustafa Ozen, E. Emamian, A. Abdi
{"title":"From Data to Knowledge: A Mini-Review on Molecular Network Modeling and Analysis for Therapeutic Target Discovery","authors":"Mustafa Ozen, E. Emamian, A. Abdi","doi":"10.33696/pharmacol.4.043","DOIUrl":null,"url":null,"abstract":"Successful drug development is a risky and lengthy process that can take over ten years and consume billions of dollars. Target discovery is a critical stage of drug development for the identification of key molecules and pathways that can be targeted by novel therapeutics to find more effective treatments. Due to the rapid development in artificial intelligence and machine learning techniques over the past decade, computational approaches have now emerged as powerful tools to unravel complex interactions within biological systems to identify novel therapeutic targets. In particular, modeling and analysis of intracellular molecular networks play a pivotal role in target discovery by enabling researchers to efficiently and simultaneously navigate massive amounts of biological data to identify potential therapeutic targets. Such technologies can significantly accelerate the prolonged process of development of innovative therapies for complex diseases. Besides highlighting the findings of the recently introduced extreme signaling failures in intracellular molecular networks, here we briefly review various methods for modeling and analysis of intracellular molecular networks and discuss how they can be utilized to predict potential drug targets within such complex signaling systems. Overall, this review emphasizes the significance of modeling and analysis of molecular networks for fast-tracking and rapid discovery of novel therapeutic targets; to pave the way for the development of more effective treatments.","PeriodicalId":8324,"journal":{"name":"Archives of Pharmacology and Therapeutics","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Pharmacology and Therapeutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33696/pharmacol.4.043","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Successful drug development is a risky and lengthy process that can take over ten years and consume billions of dollars. Target discovery is a critical stage of drug development for the identification of key molecules and pathways that can be targeted by novel therapeutics to find more effective treatments. Due to the rapid development in artificial intelligence and machine learning techniques over the past decade, computational approaches have now emerged as powerful tools to unravel complex interactions within biological systems to identify novel therapeutic targets. In particular, modeling and analysis of intracellular molecular networks play a pivotal role in target discovery by enabling researchers to efficiently and simultaneously navigate massive amounts of biological data to identify potential therapeutic targets. Such technologies can significantly accelerate the prolonged process of development of innovative therapies for complex diseases. Besides highlighting the findings of the recently introduced extreme signaling failures in intracellular molecular networks, here we briefly review various methods for modeling and analysis of intracellular molecular networks and discuss how they can be utilized to predict potential drug targets within such complex signaling systems. Overall, this review emphasizes the significance of modeling and analysis of molecular networks for fast-tracking and rapid discovery of novel therapeutic targets; to pave the way for the development of more effective treatments.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
从数据到知识:分子网络模型和治疗靶点发现分析综述
成功的药物开发是一个危险而漫长的过程,可能需要10年以上的时间,耗资数十亿美元。靶标发现是药物开发的关键阶段,用于识别关键分子和途径,这些分子和途径可以被新疗法靶向,从而找到更有效的治疗方法。由于人工智能和机器学习技术在过去十年中的快速发展,计算方法现在已经成为揭示生物系统内复杂相互作用以确定新的治疗靶点的强大工具。特别是,细胞内分子网络的建模和分析在靶点发现中起着关键作用,使研究人员能够有效地同时导航大量的生物数据以识别潜在的治疗靶点。这些技术可以显著加快复杂疾病创新疗法的长期开发进程。除了强调最近在细胞内分子网络中引入的极端信号失败的发现外,在这里我们简要回顾了细胞内分子网络建模和分析的各种方法,并讨论了如何利用它们来预测这种复杂信号系统中的潜在药物靶点。总之,这篇综述强调了分子网络的建模和分析对于快速跟踪和快速发现新的治疗靶点的重要性;为开发更有效的治疗方法铺平道路。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
From Data to Knowledge: A Mini-Review on Molecular Network Modeling and Analysis for Therapeutic Target Discovery Proto-oncogenes Crosstalk, Feedback and Expression, and Anticancer Drugs Resistance Keeping Ready against Omicron and Future Variants: Can Ivermectin Prophylactic Effects Improve the Vaccination Effects against COVID-19? POSTCOVID-19WAR Era, Interaction between Cancer-Hematologic Disorders- Diabetes Significantly Increased by COVID-19 Variants, Aggressively The Role of the General Practitioner in Vaccination against COVID-19
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1